May 01, 2019 / 12:30PM GMT
Operator
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
Now I'd like to turn the call over to David Szekeres, Senior Vice President, General Counsel Business Development and Corporate Secretary. Please proceed.
David L. Szekeres - Heron Therapeutics, Inc. - Senior VP of Business Development, General Counsel & Corporate Secretary
Thank you, Kevin. Good morning, everyone, and thank you for joining us. With me today from Heron are Barry Quart, President and Chief Executive Officer; Kimberly Manhard, Executive Vice President of Drug Development; and Mike Mathews, Senior Vice President of Pain Franchise.
Before we begin, I would like to remind you that this call will contain forward-looking statements concerning Heron's future expectations, plans, prospects, corporate strategy and performance, which constitute forward looking statements for the purposes of the Safe Harbor provision under the Private Securities
Heron Therapeutics Inc to discuss the Complete Response Letter - Conference Call Transcript
May 01, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers